CTMX icon

CytomX Therapeutics
CTMX

Overview Fund Activity

97 hedge funds and large institutions have $79.5M invested in CytomX Therapeutics in 2022 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 26 increasing their positions, 28 reducing their positions, and 40 closing their positions.

Holders
97
Holders Change
-22
Holders Change %
-18.49%
% of All Funds
1.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
26
Reduced
28
Closed
40
Calls
$37K
Puts
–
Net Calls
+$37K
Net Calls Change
+$8K

Top Buyers

1
LCM
1
Laurion Capital Management
New York
$2.33M
2
NM
2
Newtyn Management
New York
$1.96M
3
TCM
3
Tang Capital Management
California
$1.93M
4
Acadian Asset Management
4
Acadian Asset Management
Massachusetts
$3.37M
5
Renaissance Technologies
5
Renaissance Technologies
New York
$2.66M

Top Sellers

1
BlackRock
1
BlackRock
New York
$3.34M
2
RI
2
RTW Investments
New York
$5.22M
3
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
3
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$0
4
Point72 Asset Management
4
Point72 Asset Management
Connecticut
$5.03M
5
State Street
5
State Street
Massachusetts
$410K
Name Holding Trade Value Shares
Change 		Shares
Change %
Barclays
126
Barclays
United Kingdom
– -$28K -10,528 Closed
AB
127
Amalgamated Bank
New York
– -$27K -10,184 Closed
Legal & General Group
128
Legal & General Group
United Kingdom
– -$23K -8,372 Closed
AIP
129
Ameritas Investment Partners
Nebraska
– -$13K -5,010 Closed
MLICM
130
Metropolitan Life Insurance Company (MetLife)
New York
– -$12.6K -4,708 Closed
ACM
131
Aquatic Capital Management
Illinois
– -$3K -1,000 Closed
2 3 4 5
6